Correction: Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors

Prostate Cancer and Prostatic Diseases, Published online: 24 August 2023; doi:10.1038/s41391-023-00706-xCorrection: Survival outcomes of real world patients with metastatic hormone-sensitive prostate cancer who do not achieve optimal PSA response with intensified androgen deprivation therapy with docetaxel or androgen receptor pathway inhibitors

Source: Prostate Cancer and Prostatic Diseases - August 24, 2023 Category: Urology & Nephrology Authors: Georges Gebrael Nicolas Sayegh Vinay Mathew Thomas Beverly Chigarira Nishita Tripathi Yeon Jung Jo Haoran Li Kamal Kant Sahu Ayana Srivastava Taylor McFarland Benjamin L. Maughan Umang Swami Neeraj Agarwal Source Type: research